BELLANDO RANDONE, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.552
EU - Europa 6.828
AS - Asia 1.535
AF - Africa 46
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 15.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.532
RU - Federazione Russa 2.343
IT - Italia 1.694
PL - Polonia 1.399
IE - Irlanda 590
SG - Singapore 442
SE - Svezia 381
CN - Cina 375
HK - Hong Kong 334
IN - India 184
FI - Finlandia 103
JO - Giordania 84
GB - Regno Unito 74
DE - Germania 66
CH - Svizzera 59
VN - Vietnam 54
CI - Costa d'Avorio 37
ES - Italia 34
UA - Ucraina 26
KR - Corea 25
CA - Canada 19
NL - Olanda 19
TR - Turchia 16
FR - Francia 14
BE - Belgio 6
EU - Europa 6
BR - Brasile 5
JP - Giappone 5
EG - Egitto 3
IR - Iran 3
NO - Norvegia 3
RO - Romania 3
VE - Venezuela 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
GE - Georgia 2
ID - Indonesia 2
IL - Israele 2
LV - Lettonia 2
MK - Macedonia 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
TW - Taiwan 2
AT - Austria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 15.980
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.474
Warsaw 1.398
Fairfield 965
Dublin 583
Ashburn 512
Chandler 495
Woodbridge 475
Seattle 392
Cambridge 356
Houston 356
Singapore 352
Wilmington 300
Florence 234
Lawrence 208
Hong Kong 196
Altamura 194
Princeton 167
Ann Arbor 156
Moscow 136
Mumbai 125
Boston 113
Beijing 111
Rome 107
Milan 106
Shanghai 72
San Diego 58
Boardman 55
Pune 50
Bern 47
Dong Ket 44
Buffalo 43
Medford 42
Falls Church 39
Naples 39
Abidjan 37
Kent 34
Turin 31
Norwalk 27
Helsinki 25
Yubileyny 25
Bologna 22
Cagliari 21
Jacksonville 21
Seoul 21
Barcelona 20
West Jordan 20
Hillsboro 18
London 15
New York 15
Andover 14
Catania 13
Fiesole 13
Bari 12
Izmir 12
Los Angeles 12
Toronto 12
Castelliri 11
Redwood City 11
Phoenix 10
Prato 9
Guangzhou 8
Padova 8
Reggio Emilia 8
Shenzhen 8
Messina 7
Moie 7
Ferrara 6
Hefei 6
Massa 6
Palermo 6
Pisa 6
Shijiazhuang 6
Venice 6
Bonate Sotto 5
Brescia 5
Brussels 5
Cantagallo 5
Città della Pieve 5
Dearborn 5
Düsseldorf 5
Genoa 5
Lappeenranta 5
Mariano Comense 5
Munich 5
Nardò 5
Santa Cruz de Tenerife 5
Sesto Fiorentino 5
Vicenza 5
Arosio 4
Camerino 4
Chapel Hill 4
Chiusi 4
Este 4
Guidonia Montecelio 4
Iesi 4
Livorno 4
Modena 4
Oristano 4
Sassari 4
Scandicci 4
Totale 10.692
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 809
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 275
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 252
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 248
Interstitial lung disease in systemic sclerosis: Where do we stand? 241
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 236
Very Early Diagnosis of Systemic Sclerosis (Diagnosi molto precoce della Sclerosi Sistemica) VEDOSS, 2010-2015 (2020). Validazione dei segni e sintomi in uno studio prospettico osservazionale di coorte 218
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 214
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 198
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 195
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 185
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 166
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 151
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 151
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 147
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 144
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 141
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 136
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 131
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 131
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 129
A rare case of Candida glabrata spondylodiscitis: case report and literature review 126
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 126
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 126
Calcinosis in systemic sclerosis: subsets, distribution and complications 125
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 125
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 124
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 122
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 121
Treatment options in systemic sclerosis 119
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 118
Digital ulcers predict a worse disease course in patients with systemic sclerosis 116
The safety of iloprost in systemic sclerosis in a real-life experience 113
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 112
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 111
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 111
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 111
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 109
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 108
Transitional connective tissue diseases: description of four cases 108
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 107
Systemic sclerosis and infections. 105
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 105
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 103
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 102
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 101
Increased circulating levels of interleukin-33 in systemic sclerosis correlate with early disease stage and microvascular involvement 99
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 99
Immunosuppression for interstitial lung disease in systemic sclerosis. 98
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 98
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 96
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 96
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 96
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 96
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 94
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 94
From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach 93
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 93
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 92
Avascular bone necrosis: An underestimated complication of systemic sclerosis 92
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 91
Effects of rituximab in connective tissue disorders related interstitial lung disease 91
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 90
Antioxidant agents help primary Raynaud's phenomenon 90
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 90
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 90
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 90
La riabilitazione multidisciplinare del malato reumatico 89
Musculoskeletal involvement in systemic sclerosis. 87
Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid. 87
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial 86
Mixed Connective Tissue Disease, a Roundabout to Rheumatic Diseases? 86
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 86
The role of the dermatologist in Raynaud's Phenomenon: a clinical challenge 85
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 85
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 84
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 84
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 83
Stiff Skin Syndrome 82
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 81
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 81
Mycosis fungoides: from early stages to fatal central nervous system involvement 81
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 79
Bosentan fosters microvascular de-remodelling in systemic sclerosis. 78
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 78
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 78
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 77
Very early diagnosis of systemic sclerosis. 76
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 76
STRATEGIE PER IMPLEMENTARE NEL CONTESTO ITALIANO LE “RECOMMENDATIONS FOR THE IMPLEMENTATION OF SELF-MANAGEMENT STRATEGIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS” DI EULAR (2021) 75
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 75
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 75
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 75
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 73
The measurement of the endothelial glycocalyx as a new biomarker of endothelial derangement in systemic sclerosis: A challenge for the future 73
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement 72
The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis 71
Prognostic value of lung ultrasound B-lines in systemic sclerosis 71
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 71
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 69
Totale 11.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.535 0 0 0 0 236 234 231 239 216 144 207 28
2020/20211.663 117 101 104 309 81 136 98 122 159 259 99 78
2021/2022971 19 69 94 35 50 70 26 97 68 35 124 284
2022/20232.592 281 570 106 142 136 414 368 111 228 43 102 91
2023/20242.051 45 150 230 114 122 236 132 355 81 259 192 135
2024/20255.363 366 993 571 1.522 1.911 0 0 0 0 0 0 0
Totale 16.288